TBI-223 [Antibiotic]

Download Sequences

Accession ARO:3007480
DefinitionTBI-223 is a novel oxazolidinone with potentially reduced myelosuppression, compared to linezolid. TBI-223 may be considered an additional treatment against MRSA infections and potentially other Gram-positive bacteria in humans.
Drug Classoxazolidinone antibiotic
Classification2 ontology terms | Show
Parent Term(s)1 ontology terms | Show

Gordon O, et al. 2022. Microbiol Spectr 10(5):e0245121 The Novel Oxazolidinone TBI-223 Is Effective in Three Preclinical Mouse Models of Methicillin-Resistant Staphylococcus aureus Infection. (PMID 36106881)